The Australian Government is now in caretaker period. During this time, updates on this website will be published in accordance with the Guidance on Caretaker Conventions, until after the election.
2688 results found
The purpose of these procedures is to promote the integrity and accountability of the National Health and Medical Research Council (NHMRC).
The Investigator Grants 2024 CEO Introduction webinar was held on 18 January 2024. NHMRC CEO, Professor Steve Wesselingh, and Research Foundations Executive Director, Dr Julie Glover hosted the webinar. They shared tips for quality peer review and outlined what resources are available. The video is available to watch on Vimeo and a transcript is below.
The objective of the National Health and Medical Research Council (NHMRC) Global Alliance for Chronic Diseases (GACD) 2023 scheme is to fund implementation research focused on addressing non-communicable disease (NCD) risk factors associated with city environments and related health inequities.
The Targeted Call for Research (TCR): Improving physical health of people with a mental illness 2022 grant opportunity aims to stimulate research which develops effective strategies and interventions to improve the physical health of people with a severe or persistent mental illness.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2020–21. An accessible version of this document is available on the Transparency Portal.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2019–20. An accessible version of this document is available on the Transparency Portal.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2021–22. An accessible version of this document is available on the Transparency Portal.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2022–23. An accessible version of this document is available on the Transparency Portal.
It is an inspiring time for health and medical research in Australia as the National Health and Medical Research Council (NHMRC) sets the standard for achieving gender equity through its largest grant scheme, Investigator Grants.
Picato® is a prescription gel that treats skin actinic keratosis (potentially pre-cancerous sunspots). The journey to develop this product began in the 1970s when Queensland researcher, Jim Aylward, became interested in a local farming story about the healing properties of the sap of the radium weed Euphorbia peplus (E. peplus) when applied to sunspots on the skin.
MRFF – Preventive and Public Health Research Initiative – 2023 Optimising Screening, Diagnosis and Management of Obstructive Sleep Apnoea Grant Opportunity
NHMRC opened a Targeted Call for Research (TCR) into Frailty in Hospital Care: Complex Health Care on 31 October 2018 and closed on 30 January 2019. Due to an administrative issue at the close of minimum data which disadvantaged some applications, NHMRC elected to reopen this call in the interests of equity and fairness. The re-opened call closed on 21 March 2019.
NHMRC opened a Targeted Call for Research (TCR) into Per- and Poly-Fluoroalkylated Substances (PFAS) on 19 December 2018. Applications closed on 1 May 2019.